Treace John T. - 09 Mar 2023 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Chief Executive Offer, Director, 10%+ Owner
Signature: /s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Issuer symbol: TMCI
Transactions as of: 09 Mar 2023
Net transactions value: -$50,651
Form type: 4
Filing time: 10 Mar 2023, 20:00:26 UTC
Previous filing: 21 Nov 2022
Next filing: 12 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Sale	$50,651	-2,075	-0.04%	$24.41	5,539,380	09 Mar 2023	Direct	F1, F2
transaction	TMCI	Common Stock	Award	$0	+82,475	+1.5%	$0.000000	5,621,855	10 Mar 2023	Direct	F3, F4
holding	TMCI	Common Stock						1,605,000	09 Mar 2023	By Spouse	F5
holding	TMCI	Common Stock						1,471,250	09 Mar 2023	By Spouse as cotrustee of a trust dated Sept 30, 2020	F5
holding	TMCI	Common Stock						1,839,063	09 Mar 2023	As Trustee of a trust dated Sept 25, 2020	F6
holding	TMCI	Common Stock						408,816	09 Mar 2023	As Co-Trustee of a trust dated July 29, 2021	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMCI	Stock Option (Right to Buy)	Award	$0	+186,900		$0.000000	186,900	10 Mar 2023	Stock Option (Right to Buy)	186,900	$24.07	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	Includes 25,406 restricted stock units.
F3	Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4	Includes 107,881 RSUs.
F5	The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F6	The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.
F7	The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.